Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Moderna Bullish On COVID-19 Vaccine For Younger Kids To Be Ready Next Month: Reuters

Moderna Inc's (NASDAQ:MRNA) chief medical officer said that its COVID-19 vaccine for children under six years old would be ready for review by the FDA panel when it meets in June. "I think the FDA now has all of the core fundamental data they need to be able to begin an application review.…

Benzinga

Endo Acquires Six Development-Stage, Injectable Product Candidates For $35M

Endo International plc (NASDAQ: ENDP) has acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc, a subsidiary of Nevakar Inc.

Benzinga

Vertex Pharma's Stem Cell Derived Diabetes Treatment Trial Put On Hold

The FDA has instituted a clinical hold on Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) VX-880 Phase 1/2 study due to a determination that there is insufficient information to support dose escalation with the product. VX-880 is an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for type 1 diabetes (T1D). Three patients have been…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Horizon Therapeutics' Inebilizumab Scores European Approval For Spinal Cord Inflammation

The European Commission has approved Horizon Therapeutics plc's (NASDAQ:HZNP) Uplizna (inebilizumab) as monotherapy for neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 immunoglobulin G seropositive (AQP4-IgG+). NMOSD is an autoimmune disease that attacks the optic nerve, spinal cord, brain, and brain stem. In the N-MOmentum pivotal clinical trial, Uplizna demonstrated a significant reduction…

Benzinga

Sage Therapeutics, Biogen Start Rolling Submission For Zuranolone In Major Depressive Disorder

Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ:BIIB) have initiated a rolling submission of a marketing application to the FDA for zuranolone in major depressive disorder (MDD). Zuranolone is an investigational two-week, once-daily oral drug developed for MDD and postpartum depression (PPD). The companies have submitted the nonclinical module and plan to submit the remaining…

Benzinga

Farmmi Wins New Export Order

Farmmi Inc (NASDAQ:FAMI) has won a new North American sales order to Vancouver, Canada. The order is for dried Shiitake mushrooms. The financial terms were not disclosed. “With the reopening of most cities worldwide following COVID shutdowns, we are seeing a pick-up from both consumption at restaurants and in-home cooking,” said Chairwoman and…

Benzinga

Apple Under Antitrust Allegations in Brussels

Brussels regulators have accused Apple Inc (NASDAQ:AAPL) of abusing its dominant position in mobile payments to limit rivals’ access to contactless technology. Apple could face a fine of up to 10% of its global turnover or $36.6 billion based on its 2021 revenue for the alleged breach of EU competition law. Also Read: Apple To…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Could Minecraft Developers' Petition About Gaming NFT Implementation Be A Flop?

Climate Replay, an organization including developers working at Mojang — the firm behind Minecraft, acquired by Microsoft Corporation (NASDAQ: MSFT) in September 2014 — launched a petition concerning the use of non-fungible tokens (NFTs) in gaming, but it h

Benzinga

Itron Q1 Revenue Declines 9%; Margins Shrink Due To Semiconductor Crisis

Itron, Inc (NASDAQ:ITRI) reported a first-quarter FY22 revenue decline of 9% year-on-year to $475 million, missing the consensus of $488.5 million. Device Solutions revenue declined 19% Y/Y to $139.6 million, and Networked Solutions revenue reduced 3% Y/Y to $278.8 million. Outcomes revenue decreased 3% Y/Y to $56.9 million. Bookings were $417 million. The…

Benzinga

Mid-Day Market Update: Dow Drops Over 100 Points; Hilltop Holdings Shares Spike Higher

U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping more than 100 points on Monday.

Benzinga

31 Stocks Moving In Monday's Mid-Day Session

Gainers Redbox Entertainment Inc. (NASDAQ: RDBX) climbed 64.9% to $9.86. Redbox recently reported CFO transition.

Benzinga

Preview: Wrap Technologies's Earnings

Wrap Technologies (NASDAQ:WRAP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Wrap Technologies will report an earnings per share (EPS) of $-0.12.

Benzinga

Greenlight Capital Re's Earnings: A Preview

Greenlight Capital Re (NASDAQ:GLRE) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Greenlight Capital Re will report an earnings per share (EPS) of $0.25.

Benzinga

Analyst Ratings for Etsy

Over the past 3 months, 6 analysts have published their opinion on Etsy (NASDAQ:ETSY) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Earnings Outlook For TransMedics Group

TransMedics Group (NASDAQ:TMDX) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that TransMedics Group will report an earnings per share (EPS) of $-0.38.

Benzinga

New York Mortgage Trust Earnings Preview

New York Mortgage Trust (NASDAQ:NYMT) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that New York Mortgage Trust will report an earnings per share (EPS) of $0.07.

Benzinga

Preview: SeaSpine Holdings's Earnings

SeaSpine Holdings (NASDAQ:SPNE) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that SeaSpine Holdings will report an earnings per share (EPS) of $-0.35.

Benzinga

Preview: Lifevantage's Earnings

Lifevantage (NASDAQ:LFVN) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Lifevantage will report an earnings per share (EPS) of $0.11.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Earnings Outlook For Rocky Brands

Rocky Brands (NASDAQ:RCKY) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Rocky Brands will report an earnings per share (EPS) of $1.07.

Benzinga

Why Coinbase Stock Could Be Headed For A Big Reversal, And How To Trade The Break

Coinbase Global, Inc (NASDAQ: COIN) popped up 7% higher on Monday. The crypto trading platform has been trading under a descending trendline in a steep downtrend since March 30, plunging over 40% since that date to Monday’s all-time low at the $111.80 level.

Benzinga

12 Analysts Have This to Say About Skyworks Solutions

Analysts have provided the following ratings for Skyworks Solutions (NASDAQ:SWKS) within the last quarter:

Benzinga

$1000 Invested In MicroStrategy 20 Years Ago Would Be Worth This Much

MicroStrategy (NASDAQ:MSTR) has outperformed the market over the past 20 years by 9.37% on an annualized basis producing an average annual return of 16.28%. Currently, MicroStrategy has a market capitalization of $4.06 billion.

Benzinga

This Is What Whales Are Betting On CrowdStrike Holdings

A whale with a lot of money to spend has taken a noticeably bullish stance on CrowdStrike Holdings. Looking at options history for CrowdStrike Holdings (NASDAQ:CRWD) we detected 20 strange trades.

Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Qorvo: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Qorvo (NASDAQ:QRVO) and lower its price target from $150.00 to $127.00. Shares of Qorvo are trading up 1.94% over the last 24 hours, at $115.99 per share. A move to $127.00 would account for a 9.49% increase from the current…

Benzinga

Check Out What Whales Are Doing With Micron Technology

Someone with a lot of money to spend has taken a bearish stance on Micron Technology (NASDAQ:MU). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 … 602 603 604 605

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.